XORTX Therapeutics Inc. (XRTX)
0.3791
+0.0341 (9.88%)
Inactive · Last trade price on Mar 27, 2026
XORTX Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.25 | 0.86 | 2.47 | 3.45 | 10.43 | 14.92 |
Cash & Short-Term Investments | 0.25 | 0.86 | 2.47 | 3.45 | 10.43 | 14.92 |
Cash Growth | -86.80% | -65.05% | -28.25% | -66.96% | -30.04% | 10985.84% |
Accounts Receivable | 0.06 | 0.08 | 0.02 | 0.06 | 0.08 | 0.04 |
Other Current Assets | 0.07 | 0.02 | 0.19 | 0.56 | 0.38 | 1.01 |
Total Current Assets | 0.74 | 1.26 | 2.68 | 4.07 | 10.9 | 15.96 |
Net Property, Plant & Equipment | 0.01 | 0.04 | 0.03 | 0.02 | 0.09 | - |
Other Intangible Assets | 0.19 | 0.19 | 0.18 | 0.18 | 0.2 | 0.2 |
Other Long-Term Assets | 1.56 | 1.49 | 1.2 | 1.2 | 1.19 | 1.27 |
Total Assets | 2.14 | 2.68 | 4.09 | 5.47 | 12.37 | 17.43 |
Accounts Payable | 0.84 | 0.55 | 0.15 | 0.28 | 1.45 | 0.55 |
Accrued Expenses | 0.84 | 0.55 | 0.15 | 0.28 | 1.45 | 0.55 |
Current Portion of Leases | 0.02 | 0.04 | 0.04 | 0.01 | 0.07 | - |
Other Current Liabilities | 0 | 0.01 | 0.57 | 0.53 | - | - |
Total Current Liabilities | 1.71 | 1.15 | 0.91 | 1.11 | 1.51 | 0.55 |
Long-Term Leases | - | - | - | - | 0.01 | - |
Other Long-Term Liabilities | - | - | - | - | 3.85 | 3.64 |
Total Long-Term Liabilities | - | - | - | - | 3.87 | 3.64 |
Total Liabilities | 0.86 | 0.6 | 0.76 | 0.83 | 5.38 | 4.19 |
Common Stock | 20.18 | 20.18 | 18.49 | 17.06 | 16.52 | 15.83 |
Additional Paid-in Capital | 5.79 | 5.78 | 6.06 | 5.49 | 6.22 | 5.08 |
Accumulated Other Comprehensive Income | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | - |
Retained Earnings | -24.63 | -23.82 | -21.17 | -17.85 | -15.7 | -7.67 |
Shareholders' Equity | 1.28 | 2.08 | 3.34 | 4.64 | 7 | 13.24 |
Total Liabilities & Equity | 2.14 | 2.68 | 4.09 | 5.47 | 12.37 | 17.43 |
Total Debt | 0.02 | 0.04 | 0.04 | 0.01 | 0.08 | 0 |
Net Cash (Debt) | 0.24 | 0.83 | 2.43 | 3.44 | 10.36 | 14.92 |
Net Cash Growth | -71.56% | -66.03% | -29.14% | -66.82% | -30.56% | 10985.84% |
Net Cash Per Share | 0.21 | 0.87 | 4.23 | 8.67 | 34.99 | 68.16 |
Book Value | 1.28 | 2.08 | 3.34 | 4.64 | 7 | 13.24 |
Book Value Per Share | 1.16 | 2.20 | 5.80 | 11.71 | 23.64 | 60.51 |
Tangible Book Value | 1.1 | 1.9 | 3.15 | 4.47 | 6.8 | 13.04 |
Tangible Book Value Per Share | 0.99 | 2.01 | 5.48 | 11.27 | 22.96 | 59.59 |